Literature DB >> 6156412

[Efficacy of intravenous gammaglobulin in bacterial infections in Surgical Patients. Results of a controlled, randomized clinical study (author's transl)].

K H Duswald, K Müller, J Seifert, J Ring.   

Abstract

The efficacy of intravenous gammaglobulin injections against postoperative bacterial infections was investigated in a prospective randomized, controlled clinical trial in 150 patients. It was found that after postoperative administration of 20 g i. v. gammaglobulin (Intraglobin) the preoperative serum levels had already been attained on the third day (without gammaglobulin they were lower than before operation on the 8th postoperative day). By means of this substitution it was possible to reduce the number of local infections (p less than 0.01) where moderate risk existed. With more persistent infections the incidence of septicemic complications were lower (p less than 0.05). On the basis of these results the application for certain indications of high doses of intravenous gammaglobulin discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156412

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  10 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study.

Authors:  W Glinz; P J Grob; U E Nydegger; T Ricklin; F Stamm; D Stoffel; A Lasance
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

Review 3.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

4.  The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].

Authors:  H H Sedlacek; P Gronski; T Hofstaetter; E J Kanzy; H U Schorlemmer; F R Seiler
Journal:  Klin Wochenschr       Date:  1983-08-01

Review 5.  Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.

Authors:  A Cometta; J D Baumgartner; M P Glauser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lung.

Authors:  R E Schmidt; J H Hartlapp; D Niese; H J Illiger; I Stroehmann
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

7.  [Immunoglobulins in the treatment of bacterial meningitis in childhood].

Authors:  R Noack; C Szugs; H Scholz
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

8.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

9.  Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.

Authors:  G Pilz; S Kääb; G Neeser; I Class; U Schweigart; A Brähler; O Bujdoso; R Neumann; K Werdan
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

10.  [Effect of adjuvant immunoglobulin therapy on infections in patients in an surgical intensive care unit. Results of a randomized controlled study].

Authors:  H M Just; M Metzger; W Vogel; R B Pelka
Journal:  Klin Wochenschr       Date:  1986-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.